Understanding the patterns of acquired resistance to epidermal growth factor receptor (EGFR) TKI treatment has led to more effective combination therapy and continues to drive development of novel ...
Your treatment journey for non-small-cell lung cancer (NSCLC) may vary from that of others with the same diagnosis. But you’ll likely start with some of the same treatments. You’ll have lots of ...
The outlook for the EGFR inhibitor market continues to be highly promising, supported by the increasing adoption of precision medicine in oncology and the broader use of targeted therapies across ...
GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. The outdoors feels more dangerous than ever in Grounded 2, and many ...
Genetic mutations that drive cancer often occur in tumor suppressor proteins, including the p53 transcription factor which is altered in ~40-50% of cases 1,2. However, current therapies fail to target ...
In the 1960s, Kimura’s neutral theory revolutionized molecular biology by arguing most DNA changes are random, not adaptive. A new study finds beneficial mutations are far more common than Kimura’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results